High levels of the p53 inhibitor MDM4 in head and neck squamous carcinomas
- 31 October 2007
- journal article
- Published by Elsevier in Human Pathology
- Vol. 38 (10) , 1553-1562
- https://doi.org/10.1016/j.humpath.2007.03.005
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumorsNature Medicine, 2004
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2Science, 2004
- Mdm4 (Mdmx) Regulates p53-Induced Growth Arrest and Neuronal Cell Death during Early Embryonic Mouse DevelopmentMolecular and Cellular Biology, 2002
- An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2Oncogene, 2001
- Nonrandom Chromosomal Imbalances in Esophageal Squamous Cell Carcinoma Cell Lines: Possible Involvement of the ATF3 and CENPF Genes in the 1q32 AmpliconJapanese Journal of Cancer Research, 2000
- Hdmx Stabilizes Mdm2 and p53Journal of Biological Chemistry, 2000
- MdmX Protects p53 from Mdm2-Mediated DegradationMolecular and Cellular Biology, 2000
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992